All Stories

  1. Long-Term, Real-World, Kidney Function Changes with SGLT2i versus DPP4i Type 2 Diabetes without Cardiovascular or Kidney Disease

    Article • Clinical Journal of the American Society of Nephrology, June 2023, Wolters Kluwer Health

    Ofri Mosenzon

  2. Dapagliflozin reduces the risk for hospitalization in patients with type 2 diabetes

    Article • Die Diabetologie, June 2023, Springer Science + Business Media

    Ofri Mosenzon

  3. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

    Article • Diabetes Care, July 2021, American Diabetes Association

    Ofri Mosenzon, Professor Deepak L Bhatt

  4. Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring Device

    Article • Journal of Diabetes Science and Technology, July 2016, SAGE Publications

    Ofri Mosenzon